QIAGEN NV (QGEN)
42.90
+0.42
(+0.99%)
USD |
NYSE |
Sep 16, 16:00
44.50
+1.60
(+3.73%)
Pre-Market: 08:26
QIAGEN Enterprise Value : 9.709B for Sept. 16, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 16, 2026 | 9.709B |
| September 15, 2026 | 9.622B |
| September 14, 2026 | 9.498B |
| September 11, 2026 | 9.626B |
| September 10, 2026 | 9.550B |
| September 09, 2026 | 9.626B |
| September 08, 2026 | 9.601B |
| September 04, 2026 | 9.826B |
| September 03, 2026 | 9.907B |
| September 02, 2026 | 9.977B |
| September 01, 2026 | 9.810B |
| August 31, 2026 | 9.789B |
| August 28, 2026 | 9.752B |
| August 27, 2026 | 9.882B |
| August 26, 2026 | 9.804B |
| August 25, 2026 | 9.864B |
| August 24, 2026 | 9.477B |
| August 21, 2026 | 9.950B |
| August 20, 2026 | 10.12B |
| August 19, 2026 | 10.04B |
| August 18, 2026 | 9.589B |
| August 17, 2026 | 9.647B |
| August 14, 2026 | 9.719B |
| August 13, 2026 | 9.777B |
| August 12, 2026 | 9.729B |
| Date | Value |
|---|---|
| August 11, 2026 | 9.657B |
| August 10, 2026 | 9.905B |
| August 07, 2026 | 9.585B |
| August 06, 2026 | 9.467B |
| August 05, 2026 | 9.513B |
| August 04, 2026 | 9.591B |
| August 03, 2026 | 9.591B |
| July 31, 2026 | 9.399B |
| July 30, 2026 | 9.409B |
| July 29, 2026 | 9.484B |
| July 28, 2026 | 9.581B |
| July 27, 2026 | 9.333B |
| July 24, 2026 | 9.393B |
| July 23, 2026 | 9.409B |
| July 22, 2026 | 9.228B |
| July 21, 2026 | 9.219B |
| July 20, 2026 | 9.209B |
| July 17, 2026 | 9.347B |
| July 16, 2026 | 9.422B |
| July 15, 2026 | 9.366B |
| July 14, 2026 | 9.432B |
| July 13, 2026 | 9.407B |
| July 10, 2026 | 9.422B |
| July 09, 2026 | 9.521B |
| July 08, 2026 | 8.697B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Illumina, Inc. | 35.93B |
| Thermo Fisher Scientific, Inc. | 278.36B |
| Agilent Technologies, Inc. | 45.53B |
| Bio-Rad Laboratories, Inc. | 9.885B |
| Waters Corp. | 46.04B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 103.40M |
| Revenue (Quarterly) | 535.04M |
| Total Expenses (Quarterly) | 431.64M |
| EPS Diluted (Quarterly) | 0.4975 |
| Gross Profit Margin (Quarterly) | 63.17% |
| Profit Margin (Quarterly) | 19.33% |
| Earnings Yield | 4.59% |
| Operating Earnings Yield | 5.80% |
| Normalized Earnings Yield | 5.178 |